Draft Documents To Support Submission of an Electronic Common Technical Document; Availability, 66311 [2011-27658]

Download as PDF Federal Register / Vol. 76, No. 207 / Wednesday, October 26, 2011 / Notices Center for Biologics Evaluation and Research (HFM–25), Food and Drug Administration, 1401 Rockville Pike, suite 200N, Rockville, MD 20852, 301– 827–0373, mary.padgett@fda.hhs.gov. SUPPLEMENTARY INFORMATION: DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2011–N–0724] Draft Documents To Support Submission of an Electronic Common Technical Document; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice; request for comments. The Food and Drug Administration (FDA) is announcing the availability of the following draft versions of documents that support making regulatory submissions in electronic format using the electronic Common Technical Document (eCTD) specifications entitled ‘‘The eCTD Backbone Files Specification for Module 1, version 2.0’’ (which includes the U.S. regional document type definition, version 3.0) and ‘‘Comprehensive Table of Contents Headings and Hierarchy, version 2.0.’’ Supporting technical files are also being made available on the Agency Web site. These draft documents represent FDA’s major updates to Module 1 of the eCTD, which contains regional information. DATES: Submit either electronic or written comments on the draft documents by December 27, 2011. ADDRESSES: Submit written requests for single copies of the documents to the Division of Drug Information, Center for Drug Evaluation and Research (CDER), Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, rm. 2201, Silver Spring, MD 20993–0002; or Office of Communication, Outreach and Development (HFM–40), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, 1401 Rockville Pike, suite 200N, Rockville, MD 20852–1448. Send one self-addressed adhesive label to assist that office in processing your requests. See the SUPPLEMENTARY INFORMATION section for electronic access to the documents. Submit electronic comments on the draft documents to https:// www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Virginia Hussong, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, rm. 1161, Silver Spring, MD 20993, Esub@fda.hhs.gov; or Mary Padgett, jlentini on DSK4TPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 16:53 Oct 25, 2011 Jkt 226001 I. Background The eCTD is an International Conference on Harmonisation (ICH) standard based on specifications developed by ICH and its member parties. CDERCBER have been receiving submissions in the eCTD format since 2003, and the eCTD has been the standard for electronic submissions to CDER and CBER since January 1, 2008. The majority of new electronic submissions are now received in eCTD format. Since adoption of the eCTD standard, it has become necessary to update the administrative portion of the eCTD (Module 1) to reflect regulatory changes, to provide clarification of business rules for submission processing and review, to refine the characterization of promotional marketing and advertising material, and to facilitate automated processing of submissions. In preparation for the Module 1 update, FDA is making available for comment the following draft documents: • ‘‘The eCTD Backbone Files Specification for Module 1, version 2.0’’ provides specifications for creating the eCTD backbone file for Module 1 for submission to CDER and CBER. It should be used in conjunction with the guidance for industry entitled ‘‘Providing Regulatory Submissions in Electronic Format—Human Pharmaceutical Applications and Related Submissions,’’ which will be revised as part of the implementation of the updated eCTD backbone files specification. • ‘‘The Comprehensive Table of Contents Headings and Hierarchy, version 2.0’’ reflects updated headings that are specified in the draft document entitled ‘‘The eCTD Backbone Files Specification for Module 1, version 2.0,’’ as well as mappings to regulations and legislation. Supporting technical files are also being made available on the Agency Web site. The draft documents include the following changes: • Providing for processing of bundled submissions (e.g., a supplement can be applied to more than one new drug application or biologics license application), • Providing detailed contact information so that companies can specify points of contacts to discuss technical matters that may arise with a submission, PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 66311 • Clarifying headings, and • Using attributes in place of certain headings to provide flexibility for future changes without revising the specification itself. The draft documents contain complete lists of the changes to Module 1. II. Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES) either electronic or written comments regarding the draft documents. It is only necessary to send one set of comments. It is no longer necessary to send two copies of mailed comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. III. Electronic Access Persons with access to the Internet may obtain the documents at either https://www.fda.gov/Drugs/Development ApprovalProcess/FormsSubmission Requirements/ElectronicSubmissions/ ucm253101.htm, https://www.fda.gov/ BiologicsBloodVaccines/Guidance ComplianceRegulatoryInformation/ Guidances/default.htm, or https:// www.regulations.gov. Dated: October 21, 2011. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2011–27658 Filed 10–25–11; 8:45 am] BILLING CODE 4160–01–P ADVISORY COUNCIL ON HISTORIC PRESERVATION Notice of ACHP Quarterly Business Meeting Advisory Council on Historic Preservation. ACTION: Notice. AGENCY: Notice is hereby given that the Advisory Council on Historic Preservation (ACHP) will meet Thursday, November 10, 2011. The meeting will be held at 8:30 a.m. in Room M09 in the Old Post Office Building, 1100 Pennsylvania Ave., NW., Washington, DC 20004. The ACHP was established by the National Historic Preservation Act of 1966 (16 U.S.C. 470 et seq.) to advise the President and Congress on national historic preservation policy and to comment upon federal, federally assisted, and federally licensed undertakings having an effect upon properties listed in or eligible for SUMMARY: E:\FR\FM\26OCN1.SGM 26OCN1

Agencies

[Federal Register Volume 76, Number 207 (Wednesday, October 26, 2011)]
[Notices]
[Page 66311]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-27658]



[[Page 66311]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0724]


Draft Documents To Support Submission of an Electronic Common 
Technical Document; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
availability of the following draft versions of documents that support 
making regulatory submissions in electronic format using the electronic 
Common Technical Document (eCTD) specifications entitled ``The eCTD 
Backbone Files Specification for Module 1, version 2.0'' (which 
includes the U.S. regional document type definition, version 3.0) and 
``Comprehensive Table of Contents Headings and Hierarchy, version 
2.0.'' Supporting technical files are also being made available on the 
Agency Web site. These draft documents represent FDA's major updates to 
Module 1 of the eCTD, which contains regional information.

DATES: Submit either electronic or written comments on the draft 
documents by December 27, 2011.

ADDRESSES: Submit written requests for single copies of the documents 
to the Division of Drug Information, Center for Drug Evaluation and 
Research (CDER), Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 51, rm. 2201, Silver Spring, MD 20993-0002; or Office of 
Communication, Outreach and Development (HFM-40), Center for Biologics 
Evaluation and Research (CBER), Food and Drug Administration, 1401 
Rockville Pike, suite 200N, Rockville, MD 20852-1448. Send one self-
addressed adhesive label to assist that office in processing your 
requests. See the SUPPLEMENTARY INFORMATION section for electronic 
access to the documents.
    Submit electronic comments on the draft documents to https://www.regulations.gov. Submit written comments to the Division of Dockets 
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, 
rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Virginia Hussong, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 22, rm. 1161, Silver Spring, MD 20993, 
Esub@fda.hhs.gov; or Mary Padgett, Center for Biologics Evaluation and 
Research (HFM-25), Food and Drug Administration, 1401 Rockville Pike, 
suite 200N, Rockville, MD 20852, 301-827-0373, 
mary.padgett@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Background

    The eCTD is an International Conference on Harmonisation (ICH) 
standard based on specifications developed by ICH and its member 
parties. CDERCBER have been receiving submissions in the eCTD format 
since 2003, and the eCTD has been the standard for electronic 
submissions to CDER and CBER since January 1, 2008. The majority of new 
electronic submissions are now received in eCTD format. Since adoption 
of the eCTD standard, it has become necessary to update the 
administrative portion of the eCTD (Module 1) to reflect regulatory 
changes, to provide clarification of business rules for submission 
processing and review, to refine the characterization of promotional 
marketing and advertising material, and to facilitate automated 
processing of submissions. In preparation for the Module 1 update, FDA 
is making available for comment the following draft documents:
     ``The eCTD Backbone Files Specification for Module 1, 
version 2.0'' provides specifications for creating the eCTD backbone 
file for Module 1 for submission to CDER and CBER. It should be used in 
conjunction with the guidance for industry entitled ``Providing 
Regulatory Submissions in Electronic Format--Human Pharmaceutical 
Applications and Related Submissions,'' which will be revised as part 
of the implementation of the updated eCTD backbone files specification.
     ``The Comprehensive Table of Contents Headings and 
Hierarchy, version 2.0'' reflects updated headings that are specified 
in the draft document entitled ``The eCTD Backbone Files Specification 
for Module 1, version 2.0,'' as well as mappings to regulations and 
legislation.
Supporting technical files are also being made available on the Agency 
Web site.
    The draft documents include the following changes:
     Providing for processing of bundled submissions (e.g., a 
supplement can be applied to more than one new drug application or 
biologics license application),
     Providing detailed contact information so that companies 
can specify points of contacts to discuss technical matters that may 
arise with a submission,
     Clarifying headings, and
     Using attributes in place of certain headings to provide 
flexibility for future changes without revising the specification 
itself.

The draft documents contain complete lists of the changes to Module 1.

II. Comments

    Interested persons may submit to the Division of Dockets Management 
(see ADDRESSES) either electronic or written comments regarding the 
draft documents. It is only necessary to send one set of comments. It 
is no longer necessary to send two copies of mailed comments. Identify 
comments with the docket number found in brackets in the heading of 
this document. Received comments may be seen in the Division of Dockets 
Management between 9 a.m. and 4 p.m., Monday through Friday.

III. Electronic Access

    Persons with access to the Internet may obtain the documents at 
either https://www.fda.gov/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/ElectronicSubmissions/ucm253101.htm, https://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm, or 
https://www.regulations.gov.

    Dated: October 21, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-27658 Filed 10-25-11; 8:45 am]
BILLING CODE 4160-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.